Garvan Institute of Medical Research
Garvan Institute Gets A$11.6M From Australian Government to Develop Genomics-Based Disease Tests
Four teams will use genomics to improve the diagnosis and treatment of diseases including Parkinson's, inflammatory bowel disease, and rare genetic disorders.
Australian Clinical Labs, Garvan Institute Ink Pathology Services Deal
Australian Clinical Labs will take over the the clinical pathology and reporting responsibilities of Garvan Institute of Medical Research subsidiary Genome.One.
Garvan Institute's Australian Genomic Cancer Medicine Program Receives A$50M in Government Funding
With the new five-year funding, patients across Australia with rare or less common cancers will be able to access the program through a network of eight cancer centers.
OneOme, Genome.One Partner to Offer Genetic Risk, PGx Service in Australia
The two firms are offering a combined genetic disease risk and pharmacogenomic analysis that covers 49 conditions and about 220 medications.